Gabapentin Off-Label Uses: Anxiety, Sleep, and More

Gabapentin is FDA-approved for only two conditions: nerve pain after shingles (postherpetic neuralgia) and as an add-on treatment for partial seizures in epilepsy. In practice, the majority of gabapentin prescriptions are written for something else entirely. Doctors prescribe it off-label for anxiety, alcohol withdrawal, insomnia, restless legs syndrome, fibromyalgia, hot flashes, chronic itch, and several other conditions. The strength of evidence behind each use varies widely.

How Gabapentin Works Across So Many Conditions

Gabapentin’s versatility comes from its mechanism. It binds to a specific part of calcium channels on nerve cells, reducing the release of excitatory chemical signals. In simple terms, it dials down overactive nerve firing. This is why it can calm seizures, dampen pain signals, reduce anxiety, and promote sleep: all of these involve nerves that are, in one way or another, firing too much or too easily.

This same mechanism also explains why gabapentin’s side effects tend to follow it across all its uses. Drowsiness, dizziness, and fatigue are the most common complaints regardless of why someone is taking it. These effects often improve as your body adjusts, but they’re worth knowing about upfront.

Anxiety

Gabapentin has the clearest off-label evidence for social anxiety disorder, where randomized controlled trials have shown it to be effective. For generalized anxiety disorder (GAD), the picture is murkier. No controlled studies have been completed specifically for GAD. The evidence that exists comes from case reports, including one patient who remained anxiety-free for about 70 days on 1,200 mg daily, with a clear pattern of worsening anxiety at lower doses and improvement at doses above 900 mg per day.

Despite the thin research base for GAD, gabapentin is widely prescribed for it. Some clinicians favor it because it doesn’t carry the dependence risk of benzodiazepines like lorazepam or alprazolam, though gabapentin itself can cause withdrawal symptoms if stopped abruptly after long-term use.

Alcohol Use Disorder

A randomized clinical trial published in JAMA Internal Medicine found that gabapentin promotes abstinence and reduces drinking in people with alcohol use disorder, particularly those who experience more severe withdrawal symptoms. The current thinking is that gabapentin works best after someone has already stopped drinking, helping them stay sober rather than managing the acute detox itself.

This makes gabapentin appealing for a specific group: people who get significant withdrawal symptoms like tremors, sweating, or insomnia when they stop drinking. For those individuals, gabapentin can address both the lingering withdrawal discomfort and the cravings that drive relapse. It’s not a first-line treatment yet, but the evidence is building.

Insomnia and Sleep Quality

Gabapentin increases the amount of time spent in deep sleep, the restorative phase your body needs most. Studies in people with primary insomnia, alcohol dependence, and neuropathic pain have all shown improvements in deep sleep duration. A controlled trial in critically ill hospital patients found that those taking gabapentin at bedtime slept roughly 330 minutes on day three of treatment compared to about 46 minutes in the control group, with deep sleep jumping from essentially zero minutes to nearly 67 minutes.

Those are dramatic numbers from a very specific population (ICU patients), so they don’t translate directly to someone with garden-variety insomnia at home. Still, the consistent finding across different populations is that gabapentin genuinely changes sleep architecture rather than just making you drowsy. This is one reason it appeals to people who don’t respond well to traditional sleep medications or who want to avoid habit-forming options.

Restless Legs Syndrome

Gabapentin has been used off-label for restless legs syndrome (RLS) for years. In 2011, the FDA approved a modified version of the drug, gabapentin enacarbil, specifically for RLS at a once-daily 600 mg dose. The modified version provides more consistent absorption than standard gabapentin, which is absorbed erratically at higher doses.

Standard gabapentin is still commonly prescribed off-label for RLS at doses of 300 to 1,800 mg daily, typically split into two or three doses throughout the day. It was the first non-dopamine-based approach to gain traction for RLS and remains popular because dopamine-based treatments can paradoxically worsen symptoms over time, a problem called augmentation.

Fibromyalgia

The evidence for gabapentin in fibromyalgia is limited. A single controlled trial of 150 people tested doses up to 2,400 mg daily for 12 weeks. About 49% of those on gabapentin achieved at least a 30% reduction in pain, compared to 31% on placebo. When asked whether their condition had improved at all, 91% of people taking gabapentin said yes, versus 47% on placebo.

Those numbers sound promising, but a Cochrane review rated the evidence as very low quality because it rests on one small study. The 50% pain reduction threshold, often considered the benchmark for a clinically meaningful response, was never even measured. Gabapentin may help some people with fibromyalgia, but the data isn’t strong enough to say so with confidence.

Hot Flashes

For women who can’t or prefer not to take hormone therapy, gabapentin is one of the better-studied alternatives for menopausal hot flashes. At 300 mg per day over 12 weeks, gabapentin reduced hot flash frequency by about 65% and severity by about 62%, results that were comparable to estrogen therapy in the same trial. A lower dose of 100 mg per day was far less effective, cutting frequency by only 39% and severity by 24%.

This makes gabapentin a practical option for women with a history of breast cancer or blood clots who are advised against estrogen. The effect takes a few weeks to fully develop, and the dose matters considerably.

Chronic Itch in Kidney Disease

People on dialysis frequently experience intense, persistent itching that doesn’t respond to antihistamines or moisturizers. This itching is thought to originate in the nervous system rather than the skin, which is why gabapentin, a nerve-calming drug, can help. A systematic review of seven studies covering 179 dialysis patients found that six of the seven reported statistically significant improvements. On a 10-point itch scale, patients saw average reductions of 5.7 to 9.4 points within three to eight weeks.

One crossover study was particularly striking: patients’ itch scores dropped from 7.6 to 1.3 on gabapentin, then climbed back up after switching to placebo. The effective doses in these studies were low, often just 100 to 300 mg given after each dialysis session. Side effects like drowsiness and dizziness were common, and some patients had to stop the drug because of them. Kidney disease changes how the body clears gabapentin, so doses need to be much lower than those used for other conditions.

Chronic Low Back Pain

Despite being widely prescribed for it, gabapentin shows minimal benefit for chronic low back pain. A systematic review of eight randomized trials found that gabapentin produced almost no measurable improvement in pain compared to placebo, while causing significantly more side effects including dizziness, fatigue, mental fog, and visual disturbances. This is one of the weaker off-label uses from an evidence standpoint.

Side Effects Across Off-Label Uses

Regardless of why you’re taking gabapentin, the side effect profile is consistent. Drowsiness and dizziness are the most frequent complaints, followed by fatigue and sometimes swelling in the hands or feet. Mental fogginess, trouble concentrating, and visual disturbances can also occur, particularly at higher doses. These effects tend to be dose-dependent, meaning they’re more likely at 1,800 mg per day than at 300 mg.

Starting at a low dose and increasing gradually gives your body time to adjust and reduces the chance of intolerable side effects. Stopping gabapentin abruptly after taking it regularly can cause withdrawal symptoms including anxiety, insomnia, nausea, and in rare cases seizures, so tapering off under guidance is important even if you’re taking it for an off-label reason.